Latest News

Wednesday, October 29, 2014 | Product Releases

Johnson & Johnson Introduces Initial US Launch of 1-Day Acuvue Define Brand Contact Lenses

Johnson & Johnson Vision Care announced the initial launch of 1-Day Acuvue Define Brand Contact Lenses with Lacreon Technology, a new category of eye enhancement contact lenses that accentuate nat…

Read the full story

Wednesday, October 29, 2014 | Medical Studies

AMD May Progress at a Similar Rate in the Other Eye

The severity of age-related macular degeneration in one eye seems to pace the rate of degeneration in the other eye, new research has found. "In a cohort that was observed for 20 years, we showed…

Read the full story

Wednesday, October 29, 2014 | Medical Studies

iPhones for Eye Health: Capturing Ocular Images in Difficult-to-Photograph Patients

Smartphone technology is a widely available resource which may also be a portable and effective tool for imaging the inside of the eye, according to results of a study released today at AAO. Researche…

Read the full story

Tuesday, October 28, 2014 | Medical Studies

Retina Health Center Develops Imaging Device for Monitoring Patient Eye Drop Technique and Compliance

Understanding patient compliance with an eye drop regimen can greatly affect an ophthalmologist’s choice in treatments, though physicians rarely know how compliant a patient is without proper mo…

Read the full story

Tuesday, October 28, 2014 | Clinical Trials

TxCell Achieves Positive Results for Col-Treg in a Model of Autoimmune Uveitis

TxCell SA announced that TxCell researchers have achieved positive results for Col-Treg, its second product candidate from its ASTrIA platform, in a model of autoimmune uveitis, a leading cause of bli…

Read the full story

Tuesday, October 28, 2014 | Medical Studies

Pitt Researchers Receive $1.25 Million From Defense Department to Make Whole-Eye Transplantation a Reality

University of Pittsburgh School of Medicine researchers have been awarded $1.25 million from the U.S. Department of Defense (DOD) to fund two projects that aim to establish the groundwork for the nati…

Read the full story

Tuesday, October 28, 2014 | Medical Studies

AMD May Progress at a Similar Rate in the Other Eye

The severity of age-related macular degeneration (AMD) in one eye seems to pace the rate of degeneration in the other eye, new research has found. "In a cohort that was observed for 20 years, we …

Read the full story

Monday, October 27, 2014 | Acquisitions/Mergers, Valeant Ophthalmics

Valeant Ready to Raise Allergan Bid to at Least $200/share

Valeant Pharmaceuticals International Inc. on Monday said in a letter to Allergan Inc's board of directors that it was prepared to raise its offer to at least $200 per share but stopped short of d…

Read the full story

Monday, October 27, 2014 | Medical Studies

Squints Can be Treated at Any Age - Examination of Children Important in Their First Year of Life

Around 4% of all newborn children have a squint. In about 50 per cent of cases, this can be corrected with appropriate glasses, however the other half require treatment for their squint and in some ca…

Read the full story

Monday, October 27, 2014 | Miscellaneous

The Royal College of Ophthalmologists Calls for the All Party Parliamentary Group for Eye Health

The All Party Parliamentary Group (APPG) for Eye Health and Visual Impairment met with representatives from The Royal College of Ophthalmologists (RCOphth) and the College of Optometrists to discuss t…

Read the full story

Monday, October 27, 2014 |

Shire Raises Forecast Again After Earnings Beat Estimates

Shire raised its profit forecast a third time, after the drugmaker’s sales beat estimates in a quarter during which the company was occupied with AbbVie Inc. (ABBV)’s now-defunct $52 billi…

Read the full story

Friday, October 24, 2014 | Medical Studies

UK Data Presented at EURETINA 2014 Showcase Efficacy of Eylea in Clinical Practice for the Treatment of Wet AMD

Bayer HealthCare reports that data have been presented at the 14th EURETINA congress in London, showcasing the efficacy of Eylea (aflibercept) for the treatment of wet AMD in the real-life setting. Nu…

Read the full story

Friday, October 24, 2014 | Medical Studies

New Standardized DMEK Technique Saves Eyes

A new Descemet membrane endothelial keratoplasty (DMEK) technique results in low complication rates and acceptable cell density, investigators report. "We wanted to come up with a technique that …

Read the full story

Thursday, October 23, 2014 | Management/Leadership, Bausch + Lomb

Bausch + Lomb Names Tony Sommer as Head of Sales for US Vision Care Division

Bausch + Lomb has named Tony Sommer head of sales for its U.S. Vision Care division. Mr. Sommer will be responsible for managing the U.S. sales function for Bausch + Lomb’s Vision Care business.…

Read the full story

Thursday, October 23, 2014 | Medical Studies

New Study Forecasts Number of Diabetic Eye Disease Cases to Reach Nearly 11 Million by 2032

Public health agencies across the country are feeling the impact from the skyrocketing number of diabetes cases on public health programs and funding, according to a news release from Prevent Blindnes…

Read the full story
Load More

Advertisement

 Stock Price  Change 
 Aerie Pharmaceuticals, Inc. $23.85  0.00% 
 Akorn, Inc. $43.14  0.00% 
 Alimera Sciences, Inc. $6.10  0.00% 
 Allergan, Inc. $186.77  0.00% 
 Bayer $135.15  0.00% 
 Can-Fite Biopharma $2.85  0.00% 
 Carl Zeiss Meditec $21.26  -1.02% 
 Cooper Companies, Inc. $162.73  0.00% 
 Escalon Medical Corp. $1.31  0.00% 
 Essilor International $108.00  0.00% 
 Imprimis Pharmaceuticals, Inc. $8.55  0.00% 
 InSite Vision, Inc. $0.28  0.00% 
 IRIDEX Corporation $6.63  0.00% 
 Johnson & Johnson $105.56  0.00% 
 LCA-Vision Inc. $5.37  0.00% 
 Luxottica Group, S.p.A. $49.00  0.00% 
 Merck & Company, Inc. $56.20  0.00% 
 NicOx $2.16  2.27% 
 NovaBay Pharmaceuticals, Inc. $0.80  0.00% 
 Novartis AG Common Stock $91.31  0.00% 
 Ophthotech Corporation $40.32  0.00% 
 Quantel $3.28  -1.20% 
 Roche $36.73  0.00% 
 STAAR Surgical Company $10.91  0.00% 
 TearLab Corporation $2.89  0.00% 
 TLC VISION CORP $0.00  0.00% 
 Topcon Corporation $22.46  0.00% 
 Valeant Pharmaceuticals $129.76  0.00%